Beckman Coulter GenomeLab GeXP Genetic Analysis System

Wednesday, 25 May, 2011 | Supplied by: Beckman Coulter Australia

Beckman Coulter GenomeLab GeXP Genetic Analysis System

The GenomeLab GeXP Genetic Analysis System can be used to multiplex up to 30 genes in one reaction, quantitatively and reproducibly, using only a small amount of RNA sample.

The highly multiplexed reverse transcription PCR approach (XP-PCR) quickly and efficiently looks at the expression of multiplexed gene sets with greater sensitivity, speed and cost effectiveness compared to single and multiplex based-q PCR approaches.

The system can accurately detect as low as 0.5-fold changes in gene expression, providing more precise information. Powered with the universal priming strategy, XP-PCR allows multiple reference genes, genes of interest and an internal control to be unbiasedly analysed in a single well. This enables the most accurate normalisation and leads to reliable detection of very small changes in gene expression.

The system is suitable for multiplex panel validation and pathway studies. Focus areas include stem cell pluripotency studies, cancer research using FFPE samples, multiplex microbial detection for respiratory virus identification and food and beverage bacteria and yeast characterisation. The system also supports researchers who have completed their initial discovery work from the literature or large-scale screening technologies. The system is used for multiplexed, quantitative gene expression analysis as well as a multipurpose genetic analysis platform.

Online: www.beckman.com.au
Phone: 1800 060 878
Related Products

Promega Paradyme 27GY STR System

The Paradyme 27GY STR System features a novel enzyme that reduces the most common type of...

Mercodia Insulin MBeads Assay

The assay is designed to offer high accuracy by specifically measuring human insulin while...

Waters BD FACSDiscover A7 Cell Analyzer

The BD FACSDiscover A7 Cell Analyzer combines high spectral resolution and sensitivity with...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd